A Phase II Study of Telaprevir (Vx-950) in Combination With Peginterferon Alfa 2a (Pegasys) and Ribavirin (Copegus)..... Grant uri icon

Overview

total award amount

  • 137605.00

direct costs

  • 110084.00

sponsor award id

  • VX-950-106

Background

Time

date/time interval

  • January 24, 2007 - November 21, 2009

Identity

DSR Number

  • 06122111
  • 08010765
  • 08071357
  • 08100569

PeopleSoft Contract Number

  • 00063474

local award id

  • 00063474